Search Result "Anti-PD-L1"
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 3-18
Author(s): Feng Gao,Chun Yang
Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1
Journal: Reviews on Recent Clinical Trials
Volume: 15 Issue: 4 Year: 2020 Page: 339-346
Author(s): Mattia Brigida,Alessia Perricelli,Fausto Sposato,Maria Giovanna Spadafora,Angelo Pomillo,Milito Sisto
Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 4 Year: 2020 Page: 495-503
Author(s): Yingying Chen,Yuqiang Zhang,Wei Song,Ying Zhang,Xiu Dong,Mingqi Tan
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 10 Year: 2021 Page: 849-859
Author(s): Jinhuan Wei,Jun Lu,Yun Cao,Gaosheng Yao,Yong Huang,Hongwei Zhao,Yihui Pan,Zihao Feng,Zhenhua Chen,Wei Chen,Junhang Luo,Jiazheng Cao
The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 893-909
Author(s): Lifang Zhang,Yu Zhao,Quanmei Tu,Xiangyang Xue,Xueqiong Zhu,Kong-Nan Zhao
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 2 Year: 2016 Page: 141-151
Author(s): Xiao-Na Fang,Li-Wu Fu
PD-L1 Inhibitors for the Treatment of Prostate Cancer
Journal: Current Drug Targets
Volume: 21 Issue: 15 Year: 2020 Page: 1558-1565
Author(s): Matteo Santoni,Francesco Massari,Liang Cheng,Alessia Cimadamore,Marina Scarpelli,Rodolfo Montironi,Antonio Lopez-Beltran
PD-L1 Signal Transduction Mechanisms in Cancer Cells
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 17 Issue: 2 Year: 2017 Page: 72-86
Author(s): Miren Zuazo-Ibarra,Maria Gato-Canas,Hugo Arasanz-Esteban,Gonzalo Fernandez-Hinojal,Maria Ibanez-Vea,Luisa Chocarro,Ruth Vera-Garcia,David Escors,Grazyna Kochan
The Clinical Safety and Efficacy of Targeted PD-L1 Therapy with Durvalumabin Solid Tumors
Journal: Current Drug Targets
Volume: 24 Issue: 7 Year: 2023 Page: 584-598
Author(s):
Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 9 Year: 2017 Page: 839-845
Author(s): Djordje Atanackovic,Tim Luetkens,Sabari Radhakrishnan,Nicolaus Kroger